| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOMH | Common Stock | Award | +154,559 | +10% | 1,629,566 | 24 Mar 2025 | Direct | F1 | ||
| holding | DOMH | Common Stock | 116,248 | 24 Mar 2025 | By Rollover IRA | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | DOMH | Series A Warrants (right to buy) | 288,184 | 24 Mar 2025 | Common Stock | 288,184 | Direct | F3 | ||||||
| holding | DOMH | Series B Warrants (right to buy) | 288,184 | 24 Mar 2025 | Common Stock | 288,184 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On March 24, 2025, the Reporting Person was granted 154,559 shares of the Issuer's common stock by the Compensation Committee of the Issuer's board of directors. |
| F2 | The securities are directly held by the Reporting Person's Rollover IRA, and they are indirectly held by the Reporting Person. The Reporting Person exercises control over the Rollover IRA, and as such, has voting and investment power over the shares held by the Rollover IRA. |
| F3 | The Reporting Person holds Series A Warrants, which have an exercise price of $3.72 per share and expire February 14, 2030, and Series B Warrants, which have an exercise price of $4.22 and expire February 14, 2030, of the Issuer which were purchased in the Issuer's private placement offering consummated in February 2025, at a combined offering price of $3.47. |